✦ LIBER ✦

Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer

✍ Scribed by F.E de Jongh; R de Wit; J Verweij; A Sparreboom; M.J van den Bent; G Stoter; M.E.L van der Burg

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly cisplatin with oral etoposide: a

✍ W.A. VERBORG; L.R. CAMPBELL; M.S. HIGHLEY; E.M. RANKIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Cisplatin, epirubicin and paclitaxel com

✍ C. Papadimitriou; D. Lazaris; A. Rodolakis; C. Kiamouris; G.M. Gourgoulis; E. Ga 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Intravenous Busulfan Plus Melphalan Is a

✍ Partow Kebriaei; Timothy Madden; Reza Kazerooni; Xuemei Wang; Peter F. Thall; Ce 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Docetaxel (taxotere®) plus cisplatin: an

✍ T Le Chevalier; A Monnier; J.Y Douillard; P Ruffie; X.S Sun; L Belli; N Ibrahim; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Weekly carboplatin and paclitaxel is saf

✍ A. Kikuchi; H. Sakamoto; T. Yamamoto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Low-dose thalidomide in combination with

✍ Charalampia Kyriakou; Kirsty Thomson; Shirley D'Sa; Angela Flory; Judith Hanslip 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB